|
|
|
Donald C. Fresne - Founder, Chairman, and Chief Executive Officer
- More than 20 years experience in the biotechnology industry
- Former Chairman and CEO Texas Chemical and Plastics, Inc.
- Former Chairman and CEO - Resorcinol PR, Inc.
|
|
 |
|
|
|
Nils Bergenhem - PhD, President and Chief Scientific Officer
- Sixteen years of industry experience with big and small pharma (Novo Nordisk, OSI Pharmaceuticals), as well as start-ups through exit
- Drug development experience from preclinical through Phase II
- BS Chemistry Linkoping University, PhD Biochemistry
|
|
 |
|
|
|
Jedd F. Levine - MD, MBA, Chief Medical Officer
- Managing partner Connecticut Oncology and Hematology, LLC
- Former research and clinical fellow and faculty Division of Oncology, Stanford University
- MD Harvard Medical School, MBA Columbia Business School
|
|
 |
|
|
|
Nicholas J. Rossettos - CPA, MBA, Chief Financial Officer
- Former CFO Manhattan Pharmaceuticals, Inc.
- Atlantic Technology Ventures, Inc.
- BA Princeton University, MBA Northeastern University
|
|
 |
|
|
|
|
|
|
Christy Parsons - Director of Finance
- 20 years of experience in the financial services industry (Merrill Lynch, CIBC, hedge fund)
- BS University of Texas, MBA Harvard Business School
|
|
 |
